Vizgen
Latest round
- Series E
Last raised
- Dec 2025
Total raised
- $292M
Investors
- 8
About Vizgen
Vizgen, Inc. is a US-based company specializing in advanced spatial genomics solutions, particularly through its flagship product, the MERSCOPE Ultra™, which enhances single-cell analysis capabilities. Founded in 2019 in Cambridge, US, Vizgen, Inc. develops advanced spatial genomic technologies. Vizgen specializes in advanced spatial genomics solutions, particularly through their flagship product, the MERSCOPE Ultra™. This high-plex, in situ single-cell spatial genomics platform integrates single-cell and spatial multiomics analysis powered by MERFISH technology. The MERSCOPE Ultra™ automates sample imaging, analysis, and cell segmentation, enabling high-resolution and high-throughput imaging without compromising sensitivity. The platform supports customizable panels that can analyze up to 1,000 genes, catering to a diverse range of research needs across various species and tissue types. Vizgen serves research institutions and academic laboratories engaged in neuroscience and cancer research across North America, Europe, and Asia, where there is a growing demand for advanced genomic analysis tools. Vizgen generates revenue primarily through the sale of the MERSCOPE Ultra™, along with associated reagents, consumables, and lab services. Transactions typically follow a B2B model, engaging directly with research institutions and laboratories through customized partnerships that often involve subscription-based arrangements for continued access to their technology and support services. Clients may purchase MERSCOPE 1000 Plex Gene Panels and the VPT Tool for Cell Segmentation as part of their research workflows. Pricing structures are aligned with the scale of usage and specific research needs, ensuring flexible options for various client requirements. The company plans to enhance its product offerings and expand into new markets, focusing on increasing its presence in Europe and Asia by mid-2025. In January 2025, Vizgen, Inc.
Who invested in Vizgen
8 investors across 5 rounds
See all investors in Vizgen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vizgen
Who invested in Vizgen?
Vizgen has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vizgen raised?
Vizgen has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Vizgen last raise money?
Vizgen's most recent round on record is a Series E, in Dec 2025.
What does Vizgen do?
Vizgen is a biotechnology company.
Where is Vizgen headquartered?
Vizgen is headquartered in Waltham, US.
Which VCs invest in companies like Vizgen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vizgen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Vizgen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.